Pharmacokinetic considerations in antipsychotic augmentation strategies: How to combine risperidone with low-potency antipsychotics
Paulzen, Michael, Schoretsanitis, Georgios
, Stegmann, Benedikt, Hiemke, Christoph, Gründer, Gerhard, Schruers, Koen R. J., Walther, Sebastian , Lammertz, Sarah E. and Haen, Ekkehard
(2017)
Pharmacokinetic considerations in antipsychotic augmentation strategies: How to combine risperidone with low-potency antipsychotics.
Progress in Neuro-Psychopharmacology and Biological Psychiatry 76, pp. 101-106.
Date of publication of this fulltext: 20 Mar 2019 12:54
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Progress in Neuro-Psychopharmacology and Biological Psychiatry | ||||
| Publisher: | PERGAMON-ELSEVIER SCIENCE LTD | ||||
|---|---|---|---|---|---|
| Place of Publication: | OXFORD | ||||
| Volume: | 76 | ||||
| Page Range: | pp. 101-106 | ||||
| Date | 2017 | ||||
| Institutions | Human Sciences > Institut für Psychologie Chemistry and Pharmacy > Institute of Pharmacy > Pharmacology and Toxicology (Prof. Schlossmann, formerly Prof. Seifert) | ||||
| Identification Number |
| ||||
| Keywords | CYTOCHROME-P450 2D6; LEVOMEPROMAZINE; SCHIZOPHRENIA; MELPERONE; METABOLISM; CYP2D6; 9-HYDROXYRISPERIDONE; HALOPERIDOL; QUETIAPINE; INHIBITOR; Antipsychotics; Risperidone; Psychopharmacology; Pharmacokinetics; Therapeutic drug monitoring | ||||
| Dewey Decimal Classification | 100 Philosophy & psychology > 150 Psychology 500 Science > 570 Life sciences | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 38904 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric